FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Flags SK Life Sciences Xcopri TV Ad as Misleading

FDA issues an untitled letter to SK Life Science, raising concerns over a direct-to-consumer television advertisement for its seizure medication Xcopr...

latest-news-card-1
Human Drugs

Woodcock Urges Stronger FDA Role in Updating Generic Labels

Former FDA principal deputy commissioner Janet Woodcock and policy experts from Duke University call on the agency to adopt new tools and pathways to ...

latest-news-card-1
Biologics

FDA Probes Death Associated With Takedas Adzynma

FDA investigates the death of a pediatric patient with congenital thrombotic thrombocytopenic purpura who developed neutralizing antibodies to the enz...

latest-news-card-1
Human Drugs

Sterility Failures Flagged at Indian Injectable Drug Maker

FDA investigators cite Immacule Lifesciences Private Limited, a sterile drug contract manufacturer in Himachal Pradesh, India, for extensive lapses in...

latest-news-card-1
FDA General

White House Sought Resignation of Top Makary Aide

New reporting finds that the White House recently requested the resignation of a senior aide to FDA commissioner Marty Makary, highlighting growing fr...

latest-news-card-1
Medical Devices

Intersurgical Recalls Video Laryngoscope Due to Safety

Intersurgical recalls (Class 1) its i-View Video Laryngoscope, citing serious safety risks that could potentially lead to severe injury or death.

latest-news-card-1
Biologics

Makary, RFK, Jr., Feuding Over Vaccines: Politico

Politico reports that FDA commissioner Marty Makary and HHS secretary Robert F. Kennedy, Jr., are feuding over vaccine safety studies and staffing app...

Medical Devices

Medline Convenience Kit Recall is Class 1

FDA says the Medline 8/22 recall of three models of surgical convenience kits that were not sterilized is Class 1.

latest-news-card-1
Human Drugs

FDA OKs Regenerons High-Dose Eylea

FDA approves Regeneron Pharmaceuticals Eylea HD (aflibercept 8 mg) for treating macular edema following retinal vein occlusion.

latest-news-card-1
Human Drugs

Nuvalent NDA for ROS1 Inhibitor in Lung Cancer

FDA accepts for review a Nuvalent NDA for zidesamtinib, a next-generation ROS1-selective tyrosine kinase inhibitor being developed for certain adults ...